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Abstract 1 
Objective: To describe associations between presence of patellar tendon enthesis (PTE) 2 
abnormalities and symptoms, structural abnormalities, and total knee replacement (TKR) in 3 
older adult cohort.  4 
Methods: PTE abnormalities (presence of abnormal bone signal and/or bone erosion), were 5 
measured on T2-weighted magnetic resonance images at baseline in 961 community-6 
dwelling older adults. Knee pain and function limitation were assessed using Western Ontario 7 
and McMaster Universities Osteoarthritis Index (WOMAC). Bone marrow lesions (BMLs), 8 
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cartilage volume and defects score, and infrapatellar fat pad (IPFP) area were measured using 9 
validated methods. Incidence of TKR was determined by data linkage. 10 
Results: Participants with abnormal PTE bone signal and/or erosion was 20%. Cross-11 
sectionally, presence of PTE abnormalities was associated with greater pain intensity while 12 
going up and down stairs (β=0.22 (95% CI; 0.03, 0.41)), greater risk of femoral BMLs 13 
(RR=1.46 (1.12, 1.90)) and worse tibial cartilage defects score (RR=1.70 (1.16, 2.47), and 14 
smaller IPFP area (β=-0.27 (-0.47, -0.06) cm2), after adjustment of confounders. 15 
Longitudinally, presence of baseline PTE abnormalities was associated with a deleterious 16 
increase in tibial BML size (RR=1.52 (1.12, 2.05)) over 10.7 years but not symptoms, other 17 
structural changes, or TKR.  18 
Conclusion: Patellar tendon enthesis abnormalities are common in older adults. Presence of 19 
cross-sectional but not longitudinal associations suggests they are commonly co-exist with 20 
other knee structural abnormalities but may not play a major role in symptom development or 21 
structural change, excepting tibial BMLs.  22 
Keywords: patellar tendon enthesis, enthesis abnormalities, enthesopathy, osteoarthritis, 23 
MRI, knee 24 
 25 
 Introduction  26 
 27 
The signature feature of knee osteoarthritis (OA) is cartilage volume loss; however, OA is a 28 
disease of the whole joint [1, 2]. In theory, it can begin in any joint structure, including the 29 
attachment site (enthesis) of a ligament and ligaments themselves [3-5]. 30 
 31 
Entheses have high tensile strength, enabling them to dissipate mechanical stress during joint 32 
movement at the bony interface [6]. The patellar tendon enthesis (PTE) is the attachment site 33 
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of the ligament, connecting the patella to the tibia. This provides a firm anchor point to keep 34 
the patella in position and allow smooth knee bending and straightening [7, 8]. Therefore, 35 
abnormalities at the PTE may result in abnormal function and pain, particularly with 36 
activities that involve stress on the patellofemoral joint e.g. knee bending, walking up and 37 
down stairs. Evidence from histopathological studies of cruciate ligaments in cadavers [9] 38 
and magnetic resonance (MR) images of collateral ligament insertions in interphalangeal 39 
joints in hand OA [10, 11] demonstrate that abnormal enthesis changes are present in early 40 
OA, strengthening the hypothesis that entheses may play a role in OA development.  41 
 42 
While there is evidence for the importance of entheses from histopathology in knees, and MR 43 
images in hands, there is no data on associations between knee enthesis abnormalities and 44 
pain, physical function, and OA structural abnormalities in vivo, using non-invasive methods. 45 
Therefore, we aimed to describe associations between presence of PTE abnormalities visible 46 
on MR images and knee pain, physical function limitations, and OA structural abnormalities 47 
both cross-sectionally and longitudinally over 2.7 and 10.7 years and incidence of total knee 48 
replacement (TKR) over 13.3 years in a cohort of community-dwelling older adults. We 49 
hypothesised that presence of PTE abnormalities is associated with knee OA symptoms and 50 
structural abnormalities especially knee abnormalities at the patellofemoral compartment.  51 
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 Method 52 
 53 
Participants 54 
 55 
This study uses data from the Tasmanian Older Adult Cohort (TASOAC) Study. TASOAC is 56 
a prospective population-based study. Participants aged between 50 and 80 years were 57 
randomly selected from the roll of electors in southern Tasmania (population 229 000), a 58 
comprehensive population listing, using sex-stratified simple random sampling without 59 
replacement (response rate 57%). Participants attended baseline clinic between March 2002 60 
and September 2004 and follow-up clinics at (Phase 2) 2.7 and (Phase 4) 10.7 years later, on 61 
average. Additional information was available at 13.3 years through data linkage to the 62 
Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR). 63 
Figure 2 outlines the study timeline. Persons were excluded if they were institutionalised or 64 
had contraindications to magnetic resonance imaging (MRI), including metal sutures, 65 
presence of shrapnel, iron filings in the eye and claustrophobia.  66 
All participants gave written informed consent for the TASOAC study, and the research 67 
conducted was in compliance with the Declaration of Helsinki and was approved by the 68 
Southern Tasmanian Health and Medical Human Research Ethics Committee.  69 
These analyses include 961 participants with baseline MRI (Figure 3), excluding 21 patients 70 
whose MR images had artefacts at the PTE sites. Participants with and without baseline MR 71 
images had similar demographic profiles (supplementary Table 1), excepting small 72 
differences in baseline BMI (mean±SD BMI 27.7 ±4.68 vs 28.9 ±5.13 kg/m2), which were 73 
unlikely to be clinically important. 74 
 75 
MRI 76 
 77 
MRI scans of the right knee were performed at baseline, 2.7 and 10.7 years. Knees were 78 
imaged in the sagittal plane on a 1.5-T Picker unit (Cleveland, Ohio, USA; baseline and 2.7 79 
years) and a Siemens unit (Espree, Pennsylvania, USA; 10.7 year ). Image sequences 80 
included: (1) a T1-weighted fat saturation three-dimensional gradient recall acquisition in the 81 
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6 
steady state, flip angle 30°, repetition time 31ms, echo time 6.71ms, field of view 16cm, 60 82 
partitions, 512 × 512-pixel matrix, slice thickness of 1.5mm without an inter-slice gap; (2) a 83 
T2-weighted fat saturation  two-dimensional fast spin echo, flip angle 90°, repetition time 84 
3,067ms, echo time 112ms, field of view 16cm, 15 partitions, 228 × 256-pixel matrix, slice 85 
thickness of 4mm with a between-slice gap of 0.5 to 1.0mm.  86 
 87 
PTE abnormalities 88 
 89 
PTE abnormalities were assessed at baseline on T2-weighted MR images of the right knee, 90 
both proximally and distally by one trained observer (SMM), who was trained by a 91 
radiologist (AH). Participants with MR imaging artefacts which prevented clear views of 92 
PTE sites e.g. alternating bright and dark bands were excluded in the evaluation. As there 93 
was no standardised scoring system for PTE abnormalities and adjacent structural 94 
abnormalities, we developed a novel scoring system based on a previous study [9].  This 95 
system was quick to use, and implementation was straightforward, enabling reproducible 96 
scoring for a large number of participants. Features were classified as abnormal signals if the 97 
abnormalities were present on more than one consecutive slice. Presence of any abnormality 98 
was scored as 1, absence of any abnormality was scored as 0. Quantification abnormality size 99 
was not feasible due to image quality.  We defined bone signal as an increase in signal 100 
intensity (bright abnormal signal) or any abnormal marks at the bone area adjacent to the 101 
enthesis site, such as black or white bands and irregular marking next to the cortical bone 102 
(Figure 1a and 1b). We defined bone erosion as a sharply bordered dark bone lesion which is 103 
visible in two planes with a cortical break seen in at least one plane [12] (Figure 1c and 1d); 104 
and tendon signal as an increase in signal intensity of the tendon adjacent to the enthesis 105 
(Figure 1e). Deep infrapatellar bursae are fluid-filled sacs at the distal end of the patellar 106 
tendon, between the patellar tendon and the tibia; they appear as a hyperintensities on MRI 107 
[13] (Figure 1f). Intra-observer reliability was assessed in 20 randomly selected participants 108 
after a 2-week interval between the readings using kappa-statistic. 109 
The intra-rater agreement was excellent [14] for proximal tendon signal 0.88(95% CI; 0.64 to 110 
1.00) distal tendon signal 0.99 (0.97 to 1.00); proximal bone signal 0.72 (0.37 to 1.00) distal 111 
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7 
bone signal 0.82 (0.80 to 0.99); proximal, distal bone erosion, and deep infrapatellar bursa 112 
have small variability to calculate kappa.  113 
 114 
Pain, physical function limitation, and total WOMAC score 115 
 116 
Knee pain, physical function limitation, and total WOMAC score were assessed using the 117 
self-administered Western Ontario and McMaster Universities Osteoarthritis Index 118 
(WOMAC) [15] scale, which was scored using a 10-point numeric rating scale from 0 (no 119 
pain, no functional deficit) to 9 (most severe pain, most functional deficit). The WOMAC is a 120 
valid knee OA patient reported measures of pain, function limitation, and stiffness [15-17]. 121 
This study includes 5 components of knee pain and 17 components of function limitation. 122 
Participants were asked to rate how much pain, stiffness, and functional deficits they 123 
experienced on the day of their questionnaire for their right knee. Knee pain was rated while 124 
walking on a flat surface, going up and down stairs, at night while in bed, sitting or lying and 125 
standing upright. Each of the pain subscales and physical function subscales are summed to 126 
form a score for knee pain (range 0-45), function limitation (range 0-153) and total WOMAC 127 
score (pain, physical function, and stiffness) (range 0- 216).  128 
 129 
Evaluation of cartilage morphology  130 
 131 
Cartilage defects were assessed by a trained observer at baseline and 2.7 years on T1-132 
weighted MR images (score range, 0 – 4 where 0= normal and 4 indicating full-thickness 133 
chondral wear with exposure of subchondral bone), as previously described [18]. Intra-134 
observer repeatability calculated in prior study was excellent (intraclass correlation 135 
coefficient (ICC) of 0.80 – 0.94) [18]. Change in cartilage defect score from baseline to 136 
follow-up was dichotomised to 0 and 1: 0 representing no change or a decrease in cartilage 137 
defects and 1 representing an increase of 1 or more on scale 0 – 4.  138 
 139 
Knee tibial and patellar cartilage volume was measured by a trained observer on T1-weighted 140 
MR images at baseline and 10.7 years follow-up by means of image processing on an 141 
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8 
independent workstation using Osiris software as previously described [18]. The coefficient 142 
of variation (CV) was 2.1% for the medial tibia, 2.2% for the lateral tibia, and 2.6% for 143 
patella as previously reported [18, 19].  144 
 145 
Bone marrow lesions  146 
 147 
Subchondral BMLs were assessed on T2-weighted fat saturation MRI by using OsiriX 148 
software at the medial and lateral sites of tibia and femur, and patella. BMLs were defined as 149 
areas of increased signal intensity on T2-weighted, located immediately under the articular 150 
cartilage. One trained observer scored the BMLs by measuring the maximum area of the 151 
lesion at each site in mm2 using software cursors at baseline and over 10.7 years follow-up. 152 
Baseline and 10.7-year images were read paired with the chronological order known to the 153 
reader.  Intra-observer reliability using two way mixed-effects model [20] was excellent (0.98 154 
(0.96, 0.99)), at baseline and 10.7 years follow-up. A deleterious increase in BML size was 155 
defined as any change larger than the least significant criterion (52mm2) [21, 22]; this takes 156 
into account measurement error and correlations between BML measurements at baseline and 157 
10.7 years of follow-up. 158 
 159 
Infrapatellar fat pad (IPFP) area 160 
 161 
Baseline IPFP was measured by manually drawing disarticulation contours around the IPFP 162 
boundaries on a section-by-section basis on T2-weighted MR images, using Osiris software 163 
(University of Geneva). The maximum area was selected to represent the IPFP size. One 164 
observer graded IPFP area on all MRI scans; both intra- and inter-observer reliability 165 
calculated in previous study were excellent (ICC = 0.96 for intra-observer reliability, ICC = 166 
0.92 for inter-observer reliability) [23]. 167 
 168 
TKR surgery  169 
 170 
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The incidence of primary TKR between 1 March 2002 and 21 September 2016 were 171 
determined by data linkage to the AOANJRR. The AOANJRR started data collection in 172 
Tasmania in September 2000 and collects data from both public and private hospitals. Data 173 
validation against State and Territory Health Department data is done using a sequential 174 
multi-level matching proces [24]. Matched data were then obtained which included the date, 175 
side of joint replacement, primary or revision joint replacement and the reason for the 176 
procedure (e.g., OA, osteonecrosis). In this study, we only considered TKRs that were due to 177 
OA.  178 
 Additional available baseline data 179 
 180 
Weight was measured to the nearest 0.1 kg (with shoes, socks, and bulky clothing removed) 181 
by using a single pair of electronic scales (Seca Delta Model 707). Height was measured to 182 
the nearest 0.1 cm (with shoes and socks removed) by using a stadiometer. Body mass index 183 
(BMI) was calculated as kilograms per square meter. A standing anteroposterior semi-flexed 184 
view of right knee with 15° of fixed knee flexion was performed and scored individually for 185 
osteophytes and joint space narrowing (JSN) on a scale of 0 – 3 [25]. Presence of 186 
radiographic osteoarthritis was defined as any score ≥1 for JSN or osteophytes. 187 
 188 
Knee extension strength of the dominant leg measured to the nearest kg using a seated 189 
isometric contraction of the knee extensors [26]. Meniscal damage was assessed by a trained 190 
observer on T1-weighted MR images as previously described [27], and defined as presence 191 
of tear or extrusion on the meniscus dichotomised as 0=absent and ≤1=present. Presence of 192 
intra-articular fluid-equivalent signal on T2-weighted MRI at the suprapatellar pouch 193 
(suprapatellar effusion) was determined as previously described [28]. 194 
 195 
Statistical analysis  196 
 197 
The primary exposure for all analyses was presence of PTE abnormalities at baseline, defined 198 
as presence of abnormal bone signal and/or erosion at PTE.  199 
 200 
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As TASOAC is a community-based cohort, there is a mix of people with and without pain.  201 
The pain data is non-normally distributed with a large number of zeros, so exponential hurdle 202 
models were the most appropriate model to estimate associations between baseline PTE 203 
abnormalities and pain outcomes. The hurdle model has two parts: one model for the 204 
presence/absence of pain and a second, separate model for pain severity for those who 205 
reported pain. We report estimates from these models separately for each outcome as the 206 
relative risk of reporting pain and the coefficient for intensity of pain. The interaction 207 
between baseline PTE abnormalities and time was used to calculate estimated change in 208 
outcomes over 10.7 years associated with PTE abnormalities. Multivariable models were 209 
adjusted for age, sex, BMI, knee extension strength, and additionally adjusted for presence of 210 
medial tibiofemoral BMLs, cartilage defects, and suprapatellar effusions. 211 
 212 
Log binomial regression was used to assess associations between presence of PTE 213 
abnormalities at baseline and  prevalence of BMLs at baseline, deleterious increases in BML 214 
size over 10.7 years and risk of TKR incidence over 13.3 years, as well as associations with 215 
baseline cartilage defects, and risk of worsening of cartilage defects over 2.7 years. All 216 
models were adjusted for age, sex, BMI, and baseline cartilage defects. 217 
 218 
Linear regression was used to estimate associations between PTE abnormalities and 219 
infrapatellar fat pad at baseline. The models were adjusted for age, sex, BMI, interaction 220 
between age and sex, cartilage defects, and BMLs. 221 
 222 
Multilevel mixed effects regression models were used to estimate associations between PTE 223 
abnormalities and cartilage volume loss over 10.7 years. Each model included fixed effect 224 
terms for PTE abnormalities at baseline, time (years since baseline), and an interaction term 225 
for PTE abnormalities with time. The interaction term estimates the additional change in the 226 
outcome per year associated with the presence of PTE abnormalities at baseline. A random 227 
intercept was specified for each participant to account for individual differences in baseline 228 
cartilage volume, and the correlation between the repeated measurements over time was 229 
modelled using an exponential residual variance-covariance structure. Point estimates of 230 
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change in the cartilage volume loss over 10.7 years were reported for those with PTE 231 
abnormalities at baseline compared to those without PTE abnormalities. All models were 232 
adjusted for age, sex, BMI, and additionally adjusted for baseline BMLs and cartilage 233 
defects.  234 
 235 
All statistical analyses were performed using Stata 15 (Stata-Corp, College Station, Texas, 236 
USA). The significant p-value was set at the value of less than 0.05 (two-tailed). 237 
 238 
AUTHOR ACCEPTED VERSION 
 12 
 Results 239 
 240 
Of the 7 abnormalities measured, presence of tendon signal and deep infrapatellar bursa was 241 
almost ubiquitous in this group (tendon signal (proximal 97%, distal 84%); deep infrapatellar 242 
bursa 93%). Bone signal was infrequent, and bone erosion was rare (bone signal (proximal 243 
10%, distal 10%); erosion (proximal 2%, distal 2%)). Prevalence of tendon signal, bone 244 
signal, and bone erosion were similar between distal and proximal sites. Therefore, PTE 245 
abnormalities were defined as presence of bone signal and/or erosion. At baseline, 20% of 246 
participants (n=192/961) had bone signal and/or erosion at the PTE. Of these, 84% had bone 247 
signal or erosion at 1 site only, 15% at 2 sites, and <1% at ≥3 sites. 248 
 249 
Participants with and without baseline PTE abnormalities had similar demographic and 250 
structural profiles (Table 1); however, participants with PTE abnormalities were older, less 251 
female, had greater pain, and poorer physical function. They had more OA structural 252 
abnormalities (greater proportion of medial and lateral tibiofemoral BMLs, any BMLs, tibial 253 
and femoral cartilage defects), compared to participants without PTE abnormalities (Table 1).  254 
 255 
Associations between PTE abnormalities and knee pain, physical function 256 
limitation, and total WOMAC score. 257 
 258 
Presence of PTE abnormalities at baseline was associated with higher risk of presence (vs 259 
absence) of pain whilst walking on flat surfaces, going up and down stairs, pain score, 260 
function limitations score, and total WOMAC score, in the unadjusted model (Table 2). 261 
However, associations remained significant only for presence of pain whilst going up and 262 
down stairs and pain score after adjustment for demographic factors but not structural 263 
abnormalities.  264 
 265 
PTE abnormalities were associated with greater intensity of function limitation and total 266 
WOMAC score in the unadjusted model. This association persisted for physical function 267 
limitation after adjustment for demographic factors. Only the association between PTE 268 
abnormalities and pain intensity going up and down stairs remained statistically significant 269 
after further adjustment for structural abnormalities.   270 
 271 
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Longitudinally, presence of baseline PTE abnormalities were not associated with change in 272 
risk of presence (vs absence) or intensity of knee pain subscales, pain, physical function 273 
limitation, and total WOMAC score over 10.7 years in unadjusted data. Presence of PTE 274 
abnormalities at baseline conferred a 3% increase in risk of presence of physical function 275 
limitation over 10.7 years, after adjustment of demographic factors and knee extension 276 
strength (Table 2) but not after further adjustment for structural abnormalities. 277 
 278 
Bone marrow lesions  279 
 280 
Baseline PTE abnormalities were associated with higher risk of presence of tibial and femoral 281 
BMLs at baseline after adjustment for demographic confounders (Table 3). The association 282 
remained significant for presence of femoral BMLs but associations diminished for tibial 283 
BMLs after further adjustment for site-specific cartilage defects (RR=1.27 (95% CI; 0.99, 284 
1.62)). PTE abnormalities were not associated with presence of patellar BMLs at baseline. 285 
Over 10.7 years, baseline PTE abnormalities conferred a doubling of risk (RR 1.94) of a 286 
deleterious tibial BML size increase (change >52mm2), compared with a participant with no 287 
PTE abnormalities; associations persisted after adjustment for demographic and structural 288 
factors.  PTE abnormalities were not associated with increases in femoral or patellar BML 289 
size.  290 
 291 
Infrapatellar fat pad area 292 
 293 
Cross-sectionally, PTE abnormalities at baseline were negatively associated with infrapatellar 294 
fat pad area, after adjustment for demographic factors (Table 3). This association 295 
strengthened after further adjustment for cartilage defects and BMLs.  296 
 297 
Cartilage defects and volume  298 
 299 
Participants with PTE abnormalities were more likely to have tibial and femoral cartilage 300 
defects at baseline (Table 4). Associations persisted after adjustment for demographic factors, 301 
but after adjustment for structural factors (site-specific BMLs), associations only persisted for 302 
tibial cartilage defects. PTE abnormalities were not associated with patellar cartilage defects 303 
at baseline. Longitudinally, presence of baseline PTE abnormalities were not associated with 304 
change of tibial, femoral, and patellar cartilage defect score over 2.7 years. PTE 305 
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abnormalities were associated with medial tibial cartilage volume loss over 10.7 years after 306 
adjustment for demographic factors but not after adjustment of structural factors (RR=1.14 307 
(0.84, 1.55)) (Table 4). PTE abnormalities were not associated with cartilage volume loss in 308 
other compartments.  309 
 310 
Total knee replacement  311 
 312 
Baseline PTE abnormalities were not associated with the incidence of TKR surgery over 13.3 313 
years (Table 4). 314 
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 Discussion  315 
 316 
This study demonstrates that presence of PTE abnormalities (bone signal and erosion) are 317 
associated with greater pain going up and down stairs, presence of femoral BMLs, worse 318 
tibial cartilage defect score and lower infrapatellar fat pad area cross-sectionally, independent 319 
of structural confounders. However, these associations did not persist longitudinally, 320 
excepting associations with increases in tibial BML size. PTE abnormalities were not 321 
associated with the change in cartilage defects over 2.7 years, cartilage volume loss over 10.7 322 
years, or TKR over 13.3 years. This suggests that PTE abnormalities are not causally related 323 
to the knee OA process. 324 
 325 
The prevalence of abnormal changes at the PTE site in our study was 20%, comprising bone 326 
signal or erosion at 1 enthesis site (17%), 2 sites (3%) or 3 sites (n=1 person only), assessed 327 
reproducibly and non-invasively using MR imaging.  This is the first time that such 328 
abnormalities have been measured in a similar population; previous studies  investigated knee 329 
cruciate ligaments, collateral ligaments and tendon of interphalangeal joints. The 2% 330 
prevalence of enthesis bone erosion in our sample is larger than 0% (0/18 participants) in 331 
MRI images of finger joints of 18 healthy participants (age 30-72) [10], however, this study 332 
had both a small sample size and a wide age range. Bone pathology was very common at the 333 
cruciate ligament enthesis (range 22% to 69%) assessed using MRI amongst osteoarthritic 334 
patients [9], which is consistent with prevalence estimates from our study, also in older adults 335 
(10% bone signal at one enthesis site).  336 
 337 
PTE abnormalities were most strongly associated with knee pain going up and down stairs, as 338 
expected. This association was independent of demographic and structural covariates. This is 339 
the activity where patients first report knee pain [29], and is responsible for the largest stress 340 
on hips and knees during weight bearing [30, 31]. Pain while stair climbing can be explained 341 
through increase in patellofemoral pressure, lateral tilt, and force distribution on the patella 342 
[32]. Our results suggest that PTE abnormalities may be associated with knee pain intensity 343 
(possibly anterior knee pain); and that this stress may be associated with the abnormal 344 
changes that we see on the enthesis site cross-sectionally. However, the effect size was small 345 
and may not clinically important, as associations did not persist longitudinally. This is in 346 
contrast with other studies which showed that enthesis abnormalities were related to pain in 347 
inflammatory arthritis [33] and heel pain [34-36].  348 
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We are the first group to explore associations between enthesis abnormalities and joint 349 
function. We observed that PTE abnormalities were not associated with presence of 350 
functional limitation independent of demographic or structural factors cross-sectionally; 351 
however the effect sizes remained similar to pain score. PTE abnormalities were associated 352 
with severity of functional limitation after adjustment for demographic factors cross-353 
sectionally, but were not independent of structural covariates. Longitudinally, presence of 354 
PTE abnormalities were associated with a small (3%) increase in risk of worsening functional 355 
limitation over 10.7 years after adjustment for demographic factors, but this was also not 356 
independent of structural factors. 357 
 358 
While almost none of the associations between PTE abnormalities and pain or function were 359 
independent of structural factors, we did demonstrate that PTE abnormalities are associated 360 
with some structural factors: higher risk of the presence of femoral BMLs at baseline and 361 
deleterious increases in tibial BML size over 10.7 years. A weaker cross-sectional association 362 
was also seen for tibial BMLs (RR 1.27 (0.99, 1.62)) after full adjustment of covariates at 363 
baseline. Previous studies have shown that BMLs can originate from entheses [10, 11], and 364 
are commonly adjacent to ligament pathology [37]. Our study design collected data on which 365 
compartment the BMLs were in, but not specifically whether the BMLs were or were not 366 
adjacent to cruciate ligament enthesis and PTE sites. However, we hypothesise that the 367 
observed association is due to the impact of joint loading on the tibia [38, 39]. Ligament 368 
degeneration and instability changes the biomechanical joint environment and is one of the 369 
risk factors for knee osteoarthritis [40]. The patellar tendon provides joint stability [41], so 370 
this association may be due to reduced stability and strength of the patellar tendon 371 
attachments.  372 
 373 
Presence of PTE abnormalities was associated with smaller infrapatellar fat pad area, and 374 
worse tibial cartilage defects cross-sectionally; but not change in these factors longitudinally. 375 
Larger infrapatellar IPFP at baseline is protective for knee pain and cartilage damage in this 376 
cohort [23, 42]. We have no longitudinal data on infrapatellar fat pad area.  377 
 378 
The lack of consistency between cross-sectional and longitudinal associations with 379 
osteoarthritis outcomes raises questions regarding whether PTE abnormalities are related to 380 
osteoarthritis or whether it simply co-occurs with other osteoarthritic structural abnormalities. 381 
We also hypothesised that the abnormalities would be more strongly associated with patellar 382 
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abnormalities, but paradoxically our results showed no association with any patellar 383 
abnormalities. Associations between PTE abnormalities and knee pain were seen cross-384 
sectionally but not longitudinally, supporting an absence of longitudinal associations with 385 
knee OA structural abnormalities. Tan et al. suggested that enthesopathy-related osteoarthritis 386 
could be a specific subcategory of osteoarthritis [43] based on images of interphalangeal 387 
joints; however our study suggests that it may not be a major player in development of knee 388 
osteoarthritis. 389 
 390 
Strengths of our study include data from a randomly selected community-dwelling cohort, 391 
therefore the results can be generalized to community-dwelling older adults. Data collection 392 
continued for 10 years, enabling us to assess longitudinal associations. The scoring system 393 
used in this study to assess PTE abnormalities is a novel, non-invasive, simple to use, and 394 
reproducible system which used T2-weighted fat saturation MRI. Limitations of our study 395 
include a lack of standardised scoring system to assess PTE abnormalities, requiring us to 396 
develop one from the literature to suit our study. We were unable to measure the size or 397 
volume of deep infrapatellar bursae and presence of enthesophytes due to the available image 398 
quality. Better image quality would improve the sensitivity of the analysis; since we are 399 
unable to assess volume, this may underestimate the magnitude of any associations, as bursa 400 
size more than 2-3mm is considered abnormal [44].  401 
 402 
Conclusions  403 
 404 
Patellar tendon enthesis abnormalities are common in older adults. Presence of cross-405 
sectional but not longitudinal associations suggests they commonly co-exist with other knee 406 
structural abnormalities, and they may be a marker of loading manifested through BMLs.  407 
However, they may not play a major role in symptom development or structural change with 408 
the exception of tibial BMLs.  409 
 410 
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Tables 
Table 1. Characteristics of participants divided by presence of PTE abnormalities at baseline (n=961). 
 
No PTE abnormalities 
n=769 
PTE abnormalities 
n=192 
Age 62.5 (7.1) 64.4 (8.2) 
Female sex (%) 53 43 
Body Mass Index (kg/m2) 27.6 (4.6) 28.2 (4.8) 
Knee Extension (kg) 30.2 (11.1) 30.2 (11.7) 
Radiographic OA (%) 60 57 
Any meniscal tears (%) 99.5 100 
Any meniscal extrusion (%) 24 28 
Suprapatellar effusion (%) 43 39 
Any BMLs (%) 52 68 
Tibial cartilage defects (%) 18 27 
Femoral cartilage defects (%) 25 34 
Any cartilage defects (%)  52 59 
Infrapatellar fat pad area (cm2) 7.6 (1.2) 7.6 (1.2) 
Cartilage volume (cm3)   
           Medial tibial 22.8 (6.1) 23.5 (6.2) 
           Lateral tibial 27.3 (7) 28.3 (7.4) 
           Patellar  32.1 (9.6) 31.9 (9.1) 
           Medial femoral 40.5 (11.3) 40 (10.4) 
           Lateral femoral 44.7 (12.6) 45 (12.6) 
WOMAC scales   
Pain (0-45)  3.3 (5.9) 4.4 (7.0) 
Function limitation (0-153) 9.9 (19.6) 14.9 (25.1) 
Total score (0-216) 14.7 (26.8) 21.5 (34.5) 
Mean (SD) except for percentages.   
Baseline any cartilage defects score was dichotomised to normal/focal blistering (0 and 1) and any 
loss of chondral thickness (2 or more).  
Suprapatellar effusion was dichotomised to normal (0 and 1) and pathological effusion as any score of 
≥2. 
n, number; BMI, body mass index; OA, osteoarthritis; WOMAC, Western Ontario and McMaster 
Universities Osteoarthritis Index.
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Table 2. Associations of PTE abnormalities and pain, function limitation, and total WOMAC score at baseline and change over 10.7 years. 
 Univariable Multivariable 1 Multivariable 2 
 
Present/absent 
RR (95% CI) 
Intensity 
β (95% CI) 
Present/absent 
RR (95% CI) 
Intensity 
β (95% CI) 
Present/absent 
RR (95% CI) 
Intensity 
β (95% CI) 
Baseline (n=961)        
Pain subscales       
     Walking on flat surface 1.24 (1.00, 1.52) 0.10 (-0.06, 0.27) 1.18 (0.96, 1.46) 0.11 (-0.06, 0.28) 1.20 (0.90, 1.61) 0.15 (-0.08, 0.38) 
     Going up and down stairs 1.26 (1.03, 1.54) 0.14 (0.00, 0.29) 1.25 (1.02, 1.54) 0.12 (-0.03, 0.26) 1.20 (0.91, 1.58) 0.22 (0.03, 0.41) 
     At night while in bed 1.09 (0.89, 1.34) -0.12 (-0.31, 0.07) 1.04 (0.84, 1.29) -0.15 (-0.34, 0.04) 0.97 (0.72, 1.32) -0.07 (-0.34, 0.20) 
     Sitting or lying 1.22 (0.99, 1.50) 0.02 (-0.16, 0.20) 1.17 (0.95, 1.46) -0.01 (-0.19, 0.18) 1.05 (0.77, 1.42) 0.03 (-0.23, 0.28) 
     Standing upright 1.17 (0.95, 1.44) 0.10 (-0.08, 0.28) 1.11 (0.90, 1.38) 0.09 (-0.09, 0.27) 0.98 (0.73, 1.33) 0.18 (-0.07, 0.43) 
Pain score 1.26 (1.03, 1.54) 0.11 (-0.10, 0.31) 1.24 (1.01, 1.53) 0.06 (-0.14, 0.26) 1.17 (0.88, 1.54) 0.14 (-0.13, 0.41) 
Function limitation score 1.25 (1.02, 1.53) 0.35 (0.08, 0.61) 1.20 (0.97, 1.48) 0.26 (0.01, 0.52) 1.21 (0.91, 1.60) 0.27 (-0.08, 0.62) 
Total WOMAC score 1.23 (1.00, 1.51) 0.29 (0.04, 0.55) 1.18 (0.95, 1.46) 0.22 (-0.02, 0.47) 1.12 (0.84, 1.49) 0.29 (-0.05, 0.63) 
       
Change over 10.7 years     
Pain subscales       
     Walking on flat surface 1.00 (0.97, 1.03) 0.00 (-0.03, 0.03) 1.00 (0.97, 1.03) 0.00 (-0.03, 0.03) 0.99 (0.96, 1.03) 0.01 (-0.03, 0.04) 
     Going up and down stairs 1.00 (0.97, 1.03) -0.01 (-0.03, 0.02) 1.00 (0.97, 1.03) -0.01 (-0.03, 0.02) 0.99 (0.95, 1.03) -0.01 (-0.04, 0.02) 
     At night while in bed 1.02 (0.99, 1.05) 0.01 (-0.02, 0.05) 1.02 (0.99, 1.05) 0.01 (-0.02, 0.05) 1.03 (0.99, 1.06) 0.02 (-0.02, 0.05) 
     Sitting or lying 1.00 (0.97, 1.03) 0.02 (-0.02, 0.05) 1.00 (0.97, 1.03) 0.02 (-0.01, 0.06) 1.02 (0.98, 1.05) 0.02 (-0.01, 0.06) 
     Standing upright 1.02 (0.99, 1.05) -0.01 (-0.04, 0.03) 1.02 (0.99, 1.06) 0.00 (-0.03, 0.03) 1.03 (0.99, 1.07) 0.00 (-0.03, 0.04) 
Pain score 1.01 (0.98, 1.04) -0.01 (-0.05, 0.02) 1.01 (0.98, 1.04) -0.01 (-0.05, 0.02) 1.01 (0.97, 1.04) -0.01 (-0.05, 0.03) 
Function limitation score 1.03 (1.00, 1.06) -0.03 (-0.07, 0.01) 1.03 (1.00, 1.06) -0.03 (-0.07, 0.00) 1.02 (0.98, 1.06) -0.03 (-0.07, 0.02) 
Total WOMAC score 1.02 (0.99, 1.05) -0.01 (-0.05, 0.03) 1.02 (0.99, 1.06) -0.01 (-0.05, 0.02) 1.02 (0.98, 1.06) 0.02 (-0.06, 0.02) 
Bold denotes p-value<0.05 
Multivariable 1- adjusted for age, sex, BMI, knee extension strength 
Multivariable 2 – further adjusted for presence of medial tibiofemoral BMLs, cartilage defects, and suprapatellar effusion. 
Hurdle model was used to report the association of PTE abnormalities and present/absent and intensity of the outcomes compared with participants without 
PTE abnormalities. Change over 10.7 years is the estimated change in outcomes over 10.7 years associated with PTE abnormalities.
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Table 3. Associations of baseline PTE abnormalities and presence of baseline BMLs, increase in BML size 
>52mm2 over 10.7 years, and baseline infrapatellar fat pad area. 
 
Univariable Multivariable 1 Multivariable 2 
Baseline presence of BML (n=647) (RR (95%CI)) 
  
   Tibial 1.58 (1.24, 2.01) 1.41 (1.10, 1.80) 1.27 (0.99, 1.62) 
   Femoral  1.79 (1.35, 2.39) 1.68 (1.25, 2.24) 1.46 (1.12, 1.90) 
   Patellar  1.21 (0.86, 1.71) 1.25 (0.88, 1.77) 1.17 (0.89, 1.55) 
Increase in BML size >52mm2 over 10.7 years (n=489) (RR (95%CI)) 
 
   Tibial 1.94 (1.43, 2.63) 1.94 (1.42, 2.65) 1.52 (1.12, 2.05) 
   Femoral  1.19 (0.81, 1.73) 1.14 (0.78, 1.67) 1.04 (0.74, 1.48) 
   Patellar  1.67 (0.91, 3.04) 1.64 (0.91, 2.95) 1.27 (0.73, 2.22) 
Baseline Infrapatellar fat 
pad area (n=961) (β (95% 
CI)) -0.03 (-0.21, 0.16) -0.20 (-0.35, -0.05) -0.27 (-0.47, -0.06) 
Bold denotes p-value<0.05 
Multivariable 1– adjusted for age, sex, and BMI. Baseline infrapatellar fat pad were also adjusted for 
interaction of age and sex.  
Multivariable 2– baseline presence of BMLs and BML size change >52mm2 over 10.7 years were further 
adjusted for baseline cartilage defects, and baseline BMLs for change in BML size. Baseline infrapatellar 
fat pad were further adjusted for cartilage defects and BMLs.  
Baseline BML and increase in BML size were assessed using log binomial model. Baseline IPFP were 
assessed using linear regression.  
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Table 4. Association of baseline PTE abnormalities and baseline cartilage defects, improved/worsening of 
cartilage defects over 2.7 years, cartilage volume over 10.7 years and TKR incident over 13.3 years. 
 
Univariable Multivariable 1 Multivariable 2 
Baseline cartilage defects (n=961) (RR (95% CI)) 
 
   Tibial 1.73 (1.28, 2.34) 1.47 (1.09, 1.97) 1.70 (1.16, 2.47) 
   Femoral  1.44 (1.12, 1.85) 1.28 (1.01, 1.64) 1.14 (0.84, 1.55) 
   Patellar  1.15 (0.96, 1.38) 1.07 (0.90, 1.29) 0.97 (0.77, 1.21) 
Worsening of cartilage defects over 2.7 years (n=419) (RR (95% CI)) 
   Tibial 0.94 (0.60, 1.47) 0.90 (0.56, 1.44) 0.81 (0.51, 1.29) 
   Femoral  1.27 (0.96, 1.67) 1.20 (0.90, 1.59) 1.12 (0.83, 1.51) 
   Patellar  0.76 (0.48, 1.22) 0.78 (0.49, 1.25) 0.80 (0.50, 1.29) 
Change in cartilage volume over 10.7 years (n=481) (β (95% CI)) 
 
   Medial tibial -42.39 (-83.71, -1.07) -42.18 (-83.50, -0.87) -39.40 (-81.79, 3.00) 
   Lateral tibial  -25.44 (-176.99, 126.12) -24.12 (-175.67, 127.42) -15.61 (-171.48, 140.25) 
   Tibial -213.27 (-466.07, 39.52) -211.10 (-463.86, 41.66) -186.22 (-446.04, 73.61) 
   Patellar  -58.49 (-198.51, 81.53) -58.33 (-198.34, 81.69) -47.53 (-192.54, 97.48) 
Total knee replacement surgery over 13.3 years (n=961) (RR (95% CI))  
Right knee (n=40) 1.55 (0.78, 3.10) 1.42 (0.71, 2.85) 1.61 (0.64, 4.05) 
Left knee (n=42) 1.42 (0.71, 2.83) 1.23 (0.63, 2.40) 0.91 (0.36, 2.29) 
Any TKR (n=65) 1.37 (0.79, 2.37) 1.22 (0.71, 2.10) 1.01 (0.49, 2.08) 
Multivariable 1– adjusted for age, sex, and BMI 
Multivariable 2– baseline cartilage defects were further adjusted for BMLs. Worsening of cartilage defect, 
change in cartilage volume loss, and TKR were further adjusted for baseline BMLs and cartilage defects.  
Baseline and worsening of cartilage defects were assessed using log binomial regression. Change in 
cartilage volume were assessed using mixed model; β-coefficient represents 1mm3 change in cartilage 
volume over 2.7 years for those with PTE abnormalities compared to those without PTE abnormalities. 
Incident of TKR were assessed using log binomial regression.  
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Figure 1. Patellar tendon and enthesis (PTE) abnormalities measured on T2-w FSE 
MRI, indicated by white arrows. 1a shows bone signal (increased signal intensity) at the 
proximal end of PTE and 1b shows bone signal (increased signal intensity with black band) at 
the distal end of PTE. 1c shows bone erosion at the proximal end of PTE and 1d shows bone 
erosion at the distal end of PTE. 1e shows proximal and distal tendon signal, while 1f shows 
presence of deep infrapatellar bursae between the tibia, distal PTE and infrapatellar fat pad.  
Note: Tendon signal abnormalities and deep infrapatellar bursa were ubiquitous 
abnormalities and thus were not included in the scoring system for PTE abnormalities 
 
Figure 2. Study time line.  
Figure 3. Flow of study participants. n=number of participants included in the analysis. 
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Phase 1 
Baseline 
Phase 2 
2.7 years  
Phase 4 
10.7 years  
Number of knee replacements over 13.3 years 
Change in WOMAC scales  
Change in cartilage volume  
Change in BMLs size  
Change in cartilage defects 
Time 
PTE abnormalities 
WOMAC scales  
Cartilage volume  
Cartilage defects 
IPFP area  
BMLs 
Cartilage defects 
WOMAC scales  
Cartilage volume 
BMLs  
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Loss to follow-up n=104 
 
Deceased =8 
Moved interstate or overseas 
=13 
Moved to nursing home =0 
Joint replacement =2 
Physically unable =22 
    
    
   
 
 
 
Participants at Phase 2 n=857 
 
MRI machine 
decommissioned n=438 
Participants included in the analysis at Phase 1 N=961 
 
Participants at Phase 3 n=752 
 
Loss to follow-up n=105 
 
No MRI =3 
Deceased =18 
Moved interstate or overseas 
=13 
Moved to nursing home =6 
Physically unable =23 
    
    
   
    
 
 
Participants eligible for Phase 3 n=857 
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Participants at Phase 4 n=557 
 
Loss to follow-up for BMLs 
and tibial cartilage volume 
measures n=76 
No T2-weighted MRI n=2 
No MRI n=61 
No MRI at baseline n=5 
    
    
 
Loss to follow-up n=195 
 
No MRI =32 
Deceased =31 
Moved interstate or overseas 
=19 
Moved to nursing home =8 
Joint replacement =19 
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Supplementary table. 
Table 5. The demographic differences between participants included and excluded (without MRI scans (n=116) 
and artefacts at PTE sites (n=21)) in this study analysis at baseline.   
 
Participants 
with MRI 
(n=961) 
Participant 
without MRI 
(n=137) p-value 
Age 62.9 (7.4) 64.1 (8.2) 0.086 
Female sex (%) 51 53 0.732 
BMI (kg/m2) 27.7 (4.7) 28.9 (5.1) 0.006 
Knee Extension (kg) 30.2 (11.2) 28.3 (10.9) 0.060 
Radiographic OA (%) 59 60 0.878 
Mean(SD) except for percentages. 
 
 
 
